Ondine Biomedical Inc. (AIM:OBI)
London
· Delayed Price · Currency is GBP · Price in GBX 10.25
0.00 (0.00%)
Mar 28, 2025, 3:51 PM GMT+1
Ondine Biomedical Market Cap
Ondine Biomedical has a market cap or net worth of 41.65 million as of March 28, 2025. Its market cap has increased by 90.84% in one year.
Market Cap
41.65M
Enterprise Value
41.15M
Revenue
944.68K
Ranking
n/a
PE Ratio
n/a
Stock Price
10.25
Market Cap Chart
Since December 6, 2021, Ondine Biomedical's market cap has decreased from 112.86M to 41.65M, a decrease of -63.10%. That is a compound annual growth rate of -26.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 41.65M | 17.14% |
| Dec 31, 2024 | 35.55M | 79.20% |
| Dec 29, 2023 | 19.84M | -50.26% |
| Dec 30, 2022 | 39.89M | -63.06% |
| Dec 31, 2021 | 107.99M | -4.31% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 173.61B |
| GSK plc | 60.23B |
| Haleon | 34.51B |
| Smith & Nephew | 9.32B |
| ConvaTec Group | 5.28B |
| Hikma Pharmaceuticals | 4.40B |
| HUTCHMED (China) | 2.01B |
| Genus | 1.25B |